A 2023 case series in Headache: The Journal of Head and Face Pain (Robbins et al.) reviewed 847 patients starting semaglutide and found: 14% reported headaches during the first 16 weeks Of those, 23% noted clear positional worsening (worse lying down or worse standing, depending on individual CSF dynamics) 89% of positional headaches resolved by week 20 without intervention beyond hydration 2.1% required temporary dose reduction 0.4% discontinued due to intolerable headache The positional component is underreported because patients don't always connect the pattern
We can help you overcome your weight challenges, reach your ideal weight and maintain it long term
Int J Vitam Nutr Res, DOI: 10.1024/0300-9831.75.2.156 Molfino, A., Cascino, A., Conte, C., Ramaccini, C., Fanelli, F
So we, our solution specifically, we're not violating any terms of a PBM contract
Yes, a consultation with a licensed healthcare provider is a legal and safety requirement for obtaining any GLP-1 medication